Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Bertocci

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 26, 2007
Simultaneous determination of serum concentrations of levodopa, dopamine, 3-O-methyldopa and alpha-methyldopa by HPLCChiara Muzzi, Erica Bertocci, Lucia Terzuoli, et al.
Electrophoresis|January 16, 2009
Relationship between Hpt polymorphisms and serum protein electropherogramRoberto Guerranti, Erica Bertocci, Chiara Muzzi, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2015
"Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014Michele Maio, Erica Bertocci, Lorenzo Pilla, et al.
Proteomics|January 19, 2008
Proteomic analysis of the pathophysiological process involved in the antisnake venom effect of Mucuna pruriens extractRoberto Guerranti, Ifeanyi G Ogueli, Erica Bertocci, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893Anusha Kalbasi, Ester Fonsatti, Pier Giorgio Natali, et al.
Journal of Cellular Physiology|July 28, 2011
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implicationsLuana Calabrò, Luca Sigalotti, Ester Fonsatti, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2017
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13-15, 2016Vincenzo Russo, Carla Chiarucci, Maria Fortunata Lofiego, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2016
"Cancer Bio-Immunotherapy in Siena": Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015Michele Maio, Erica Bertocci, Carolina Fazio, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programmeAnna Maria Di Giacomo, Luana Calabrò, Riccardo Danielli, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2010
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)Anna Maria Di Giacomo, Riccardo Danielli, Luana Calabrò, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 26, 2007
Simultaneous determination of serum concentrations of levodopa, dopamine, 3-O-methyldopa and alpha-methyldopa by HPLCChiara Muzzi, Erica Bertocci, Lucia Terzuoli, et al.
Electrophoresis|January 16, 2009
Relationship between Hpt polymorphisms and serum protein electropherogramRoberto Guerranti, Erica Bertocci, Chiara Muzzi, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2015
"Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014Michele Maio, Erica Bertocci, Lorenzo Pilla, et al.
Proteomics|January 19, 2008
Proteomic analysis of the pathophysiological process involved in the antisnake venom effect of Mucuna pruriens extractRoberto Guerranti, Ifeanyi G Ogueli, Erica Bertocci, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893Anusha Kalbasi, Ester Fonsatti, Pier Giorgio Natali, et al.
Journal of Cellular Physiology|July 28, 2011
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implicationsLuana Calabrò, Luca Sigalotti, Ester Fonsatti, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2017
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13-15, 2016Vincenzo Russo, Carla Chiarucci, Maria Fortunata Lofiego, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2016
"Cancer Bio-Immunotherapy in Siena": Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015Michele Maio, Erica Bertocci, Carolina Fazio, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programmeAnna Maria Di Giacomo, Luana Calabrò, Riccardo Danielli, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2010
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)Anna Maria Di Giacomo, Riccardo Danielli, Luana Calabrò, et al.
Pageof 1